文献速递腹部技术与安全CTMR

CT与磁共振mDIXON-Quant序列诊断轻度肝脂肪变性的比较

Comparison of CT and magnetic resonance mDIXON-Quant sequence in the diagnosis of mild hepatic steatosis.
PubMed 文献 · Br J Radiol · 2018-07-20

前瞻性纳入169名志愿者,均行CT与MR mDIXON-Quant检查,以mDIXON-Quant为标准比较CT L、CT L/S、CT L-S诊断肝脂肪变性≥5%、≥10%、≥15%的效能。65例存在轻度肝脂肪变性,三种CT方法与mDIXON-Quant强相关,对≥10%的诊断一致性更好,CT与mDIXON-Quant可准确量化轻度肝脂肪变性。

要点

  • CT L、CT L/S、CT L-S三种方法与mDIXON-Quant测量肝脂肪变性均强相关
  • 诊断肝脂肪变性≥10%时三种CT方法与mDIXON-Quant一致性更好
  • CT L诊断≥5%、≥10%、≥15%的敏感度分别为64.6%、91.3%、100%

核心结论

  • 三种CT方法与mDIXON-Quant成像在诊断肝脂肪变性≥10%时一致性更好,CT与mDIXON-Quant可作为准确定量轻度肝脂肪变性的合适工具。

研究设计与样本

  • 前瞻性研究纳入169名志愿者,每名受试者均行CT与MR mDIXON-Quant检查,以mDIXON-Quant结果为参考标准。

关键影像表现/征象

  • 65名受试者存在轻度肝脂肪变性
  • mDIXON-Quant测量的肝脂肪变性与三种CT方法强相关

诊断标准与关键数值

  • CT L诊断肝脂肪变性≥5%、≥10%、≥15%的敏感度分别为64.6%、91.3%、100%,特异度分别为90.4%、89.7%、93.0%,截断值分别为58.9、56.5、52.8 HU
  • CT L/S诊断肝脂肪变性≥5%、≥10%、≥15%的敏感度分别为50.8%、87.0%、100%,特异度分别为96.2%、98.6%、97.5%,截断值分别为1.06、0.98、0.90 HU
  • CT L-S诊断肝脂肪变性≥5%、≥10%、≥15%的敏感度分别为67.7%、87.0%、100%,特异度分别为81.7%、98.6%、97.5%,截断值分别为6.21、-1.04、-4.93 HU

临床应用与阅片要点

  • 作者认为CT与mDIXON-Quant可准确定量轻度肝脂肪变性,三种CT方法在诊断肝脂肪变性≥10%时与mDIXON-Quant一致性更好。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE:: To determine the diagnostic performance of CT in the assessment of mild hepatic steatosis by comparison with MR mDIXON-Quant as a reference standard, and to explore their clinical applications.

METHODS:: In this prospective study 169 volunteers were included. Each subject underwent CT and MR mDIXON-Quant examinations. Hepatic steatosis evaluations were performed via liver attenuation alone (CT L), liver to spleen attenuation ratio (CT L/S), difference between liver and spleen attenuation (CT L-S), and MR mDIXON-Quant imaging. The effectiveness of CT L, CT L/S, and CT L-S in diagnosing hepatic steatosis severity of ≥5%, ≥10%, and ≥15% was compared, using mDIXON-Quant results as standard.

RESULTS:: 65 subjects exhibited mild hepatic steatosis. Hepatic steatosis measurement with mDIXON-Quant was strongly correlated with the three CT methods. Using cutoff value, the sensitivity and specificity of diagnosing hepatic steatosis ≥5, ≥10, and ≥15% were 64.6, 91.3, 100%, and 90.4, 89.7, 93.0% for CT L; 50.8, 87.0, 100%, and 96.2, 98.6, 97.5% for CT L/S; and 67.7, 87.0, 100%, and 81.7, 98.6, 97.5% for CT L-S, respectively. ROC analysis indicated that 58.9, 56.5, and 52.8 HU for CT L; 1.06, 0.98, and 0.90 HU for CT L/S; and 6.21,-1.04, and -4.93 HU for CT L-S were cutoff values for diagnosing hepatic steatosis ≥5%,≥10%, and ≥15%, respectively.

CONCLUSIONS:: The three CT methods exhibit better agreements with mDIXON-Quant imaging for diagnosing hepatic steatosis ≥10%. Hence, CT and mDIXON-Quant could serve as suitable tools for the accurate quantification of mild hepatic steatosis.

SIGNIFICANT FINDS OF THE STUDY:: The close agreement between the three different CT methods (based on our cutoff values) and mDIXON-Quant imaging suggests that CT could accurately diagnose hepatic steatosis ≥10%. Thus, CT and mDIXON-Quant imaging can accurately measure mild hepatic steatosis.

WHAT THIS STUDY ADDS:: Only few studies have compared hepatic steatosis quantification between CT and mDIXON-Quant. We are the first to determine the diagnostic performance of unenhanced CT for quantitatively assessing mild hepatic steatosis, in reference to magnetic resonance mDIXON-Quant imaging.

来源:Br J Radiol,查看原文。版权归原作者所有。

引用

  1. Zhang Y, Wang C, Duanmu Y, et al. Comparison of CT and magnetic resonance mDIXON-Quant sequence in the diagnosis of mild hepatic steatosis. Br J Radiol. 2018. PMID: 30028193. doi:10.1259/bjr.20170587

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。